Skip to main content

Table 2 Summarized results of the two-way analysis of variance

From: Serum albumin levels as a predictive biomarker for low-load resistance training programs’ effects on muscle thickness in the community-dwelling elderly Japanese population: interventional study result

 

n(female:male)

muscle thickness(mm)

time

group

interaction

pre

pre

post

low

normal

low

normal

low

normal

p value

WBC

17(15:2)

52(34:18)

23.9 ± 4.6

27.6 ± 5.0

27.7 ± 5.3

30.1 ± 5.3

< 0.001

0.0306

0.082

RBC

17(14:3)

52(35:17)

24.5 ± 4.6

27.3 ± 5.1

27.4 ± 5.2

30.2 ± 5.3

< 0.001

0.0461

0.9887

Hb

16(15:1)

53(34:19)

23.8 ± 3.1

27.5 ± 5.3

26.8 ± 3.9

30.3 ± 5.5

< 0.001

0.0118

0.8063

Ht

17(15:2)

52(34:18)

25.2 ± 4.4

27.1 ± 5.3

27.7 ± 5.2

30.1 ± 5.4

< 0.001

0.1295

0.5764

MCV

17(12:5)

52(37:15)

26.7 ± 5.0

26.6 ± 5.2

29.1 ± 4.7

29.6 ± 5.6

< 0.001

0.8868

0.5129

MCH

17(14:3)

52(35:17)

25.2 ± 4.6

27.1 ± 5.2

28.7 ± 4.8

29.8 ± 5.6

< 0.001

0.297

0.2858

MCHC

13(12:1)

56(37:19)

25.0 ± 5.8

27.0 ± 4.9

29.5 ± 4.8

29.5 ± 5.5

< 0.001

0.5249

0.0146

PLT

17(9:8)

52(40:12)

27.1 ± 5.1

26.5 ± 5.2

29.5 ± 4.4

29.5 ± 5.7

< 0.001

0.8204

0.4596

TP

17(11:6)

52(38:14)

23.4 ± 3.6

27.7 ± 5.1

26.9 ± 4.9

30.3 ± 5.3

< 0.001

0.0057

0.2622

Alb

14(9:5)

55(40:15)

25.4 ± 5.1

27.0 ± 5.1

26.5 ± 4.7

30.3 ± 5.3

< 0.001

0.0791

0.003

AST(GOT)

16(11:5)

53(38:15)

27.1 ± 4.4

26.5 ± 5.4

30.4 ± 4.7

29.2 ± 5.6

< 0.001

0.5378

0.4372

ALT(GPT)

15(12:3)

54(37:17)

24.6 ± 3.2

27.2 ± 5.4

27.6 ± 4.0

30.0 ± 5.6

< 0.001

0.0902

0.8594

ALP

15(9:6)

54(40:14)

27.3 ± 5.4

26.5 ± 5.1

30.0 ± 5.7

29.3 ± 5.3

< 0.001

0.6309

0.8943

LAP

16(12:4)

53(37:16)

24.8 ± 3.9

27.2 ± 5.4

27.9 ± 4.0

30.0 ± 5.7

< 0.001

0.1252

0.6677

LD(LDH)

17(10:7)

52(39:13)

28.7 ± 4.6

26.0 ± 5.1

31.3 ± 5.0

28.9 ± 5.4

< 0.001

0.068

0.5984

γ-GTP

14(13:1)

55(36:19)

23.8 ± 3.6

27.4 ± 5.2

26.2 ± 3.6

30.3 ± 5.5

< 0.001

0.0105

0.4903

TG

17(15:2)

52(34:18)

23.6 ± 3.3

27.6 ± 5.2

26.4 ± 4.3

30.5 ± 5.4

< 0.001

0.0038

0.9606

TC

17(9:8)

52(40:12)

27.4 ± 4.8

26.4 ± 5.3

29.3 ± 5.7

29.5 ± 5.3

< 0.001

0.7951

0.1247

HDL-C

17(9:8)

52(40:12)

28.7 ± 4.7

26.0 ± 5.1

32.0 ± 4.1

28.7 ± 5.5

< 0.001

0.0326

0.4299

LDL-C

17(9:8)

52(40:12)

27.2 ± 5.8

26.5 ± 4.9

28.7 ± 5.6

29.7 ± 5.3

< 0.001

0.9126

0.0105

HbA1c

15(10:5)

54(39:15)

28.1 ± 4.8

26.3 ± 5.2

31.1 ± 4.2

29.0 ± 5.6

< 0.001

0.1987

0.7482

FBS

16(13:3)

53(36:17)

27.0 ± 5.7

26.6 ± 5.0

30.7 ± 5.5

29.1 ± 5.3

< 0.001

0.4946

0.102

  1. Data of muscle thickness are presented as mean ± SD
  2. WBC white blood cell count, RBC red blood cell count, Hb hemoglobin, Ht hematocrit, MCV mean corpuscular volume, MCH mean corpuscular hemoglobin, MCHC mean corpuscular hemoglobin concentration, PLT platelet count, TP total protein, Alb albumin, AST(GOT) aspartate aminotransferase (glutamic oxaloacetic transaminase), ALT(GPT) alanine aminotransferase (glutamic pyruvic transaminase), ALP alkaline phosphatase, LAP leucine aminopeptidase, LD(LDH) lactate dehydrogenase, γ-GTP γ-glutamyltransferase, TG triglyceride, TC total cholesterol, HDL-C high-density lipoprotein cholesterol, LDL-C low-density lipoprotein cholesterol, HbA1c hemoglobin A1c, FBS fasting blood sugar
Back to article page

BMC Geriatrics

ISSN: 1471-2318

Contact us